DE69307527D1 - Verfahren zur herstellung von taxan-derivaten - Google Patents

Verfahren zur herstellung von taxan-derivaten

Info

Publication number
DE69307527D1
DE69307527D1 DE69307527T DE69307527T DE69307527D1 DE 69307527 D1 DE69307527 D1 DE 69307527D1 DE 69307527 T DE69307527 T DE 69307527T DE 69307527 T DE69307527 T DE 69307527T DE 69307527 D1 DE69307527 D1 DE 69307527D1
Authority
DE
Germany
Prior art keywords
pct
vii
date apr
sec
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69307527T
Other languages
English (en)
Other versions
DE69307527T2 (de
Inventor
Alain Commercon
Eric Didier
Elie Fouque
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9434120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69307527(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Application granted granted Critical
Publication of DE69307527D1 publication Critical patent/DE69307527D1/de
Publication of DE69307527T2 publication Critical patent/DE69307527T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE69307527T 1992-10-05 1993-10-04 Verfahren zur herstellung von taxan-derivaten Expired - Lifetime DE69307527T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9211742A FR2696459B1 (fr) 1992-10-05 1992-10-05 Procédé de préparation de dérivés du taxane.
PCT/FR1993/000968 WO1994007878A1 (fr) 1992-10-05 1993-10-04 Procede de preparation de derives du taxane

Publications (2)

Publication Number Publication Date
DE69307527D1 true DE69307527D1 (de) 1997-02-27
DE69307527T2 DE69307527T2 (de) 1997-05-22

Family

ID=9434120

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69307527T Expired - Lifetime DE69307527T2 (de) 1992-10-05 1993-10-04 Verfahren zur herstellung von taxan-derivaten

Country Status (31)

Country Link
US (1) US5637723A (de)
EP (1) EP0663907B1 (de)
JP (1) JP3014761B2 (de)
KR (1) KR100297197B1 (de)
CN (1) CN1048983C (de)
AT (1) ATE147735T1 (de)
AU (1) AU689081B2 (de)
CA (1) CA2146155C (de)
CZ (1) CZ283362B6 (de)
DE (1) DE69307527T2 (de)
DK (1) DK0663907T3 (de)
EE (1) EE03125B1 (de)
ES (1) ES2096329T3 (de)
FI (1) FI109791B (de)
FR (1) FR2696459B1 (de)
GE (1) GEP19981299B (de)
GR (1) GR3022285T3 (de)
HU (1) HU223775B1 (de)
LT (1) LT3439B (de)
LV (1) LV10858B (de)
MX (1) MX9305767A (de)
NO (1) NO310412B1 (de)
NZ (1) NZ256446A (de)
PL (1) PL179147B1 (de)
RU (1) RU2116302C1 (de)
SG (1) SG63619A1 (de)
SK (1) SK280624B6 (de)
TW (1) TW262471B (de)
UA (1) UA43835C2 (de)
WO (1) WO1994007878A1 (de)
ZA (1) ZA937319B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794523B2 (en) 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
FR2697522B1 (fr) * 1992-10-30 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
FR2698361B1 (fr) * 1992-11-20 1995-01-13 Rhone Poulenc Rorer Sa Procédé de préparation d'un acide oxazolidine-1,3 carboxylique-5.
FR2698871B1 (fr) 1992-12-09 1995-02-24 Rhone Poulenc Rorer Sa Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
IL107950A (en) 1992-12-15 2001-04-30 Upjohn Co b 7, b 8 - Matano - Taxols, their preparation and pharmaceutical preparations against malignant tumors containing them
ES2145829T3 (es) * 1993-06-11 2000-07-16 Upjohn Co Uso antineoplasico de delta 6,7-taxoles y composiciones farmaceuticas que los contienen.
FR2706457B1 (fr) * 1993-06-16 1995-07-28 Rhone Poulenc Rorer Sa Procédé de préparation d'un acide oxazolidinecarboxylique utile pour préparer des taxoïdes thérapeutiquement actifs.
IL127599A (en) * 1994-01-28 2004-06-01 Upjohn Co Process for preparing isotaxol analogs
CA2170661A1 (en) 1995-03-22 1996-09-23 John K. Thottathil Novel methods for the preparation of taxanes using oaxzolidine intermediates
US6372780B2 (en) 1995-03-27 2002-04-16 Aventis Pharma S.A. Methods of treating cell lines expressing multidrug resistance P-glycoprotein
MA23823A1 (fr) 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US5847170A (en) * 1995-03-27 1998-12-08 Rhone-Poulenc Rorer, S.A. Taxoids, their preparation and pharmaceutical compositions containing them
WO1998013359A1 (de) * 1996-09-24 1998-04-02 Marigen S.A. Ultramikroemulsionen aus spontan dispergierbaren konzentraten mit antitumoral und antiviral wirksamen estern von baccatin-iii-verbindungen
FR2771092B1 (fr) * 1997-11-18 1999-12-17 Rhone Poulenc Rorer Sa Procede de preparation de derives de la classe des taxoides
US6096250A (en) * 1998-03-06 2000-08-01 Caesar International, Inc. Process for releasing a runner from an electronic device package on a laminate plate
US6156789A (en) * 1998-03-17 2000-12-05 Rhone-Poulenc Rorer S.A. Method for treating abnormal cell proliferation in the brain
US6346543B1 (en) 1998-08-17 2002-02-12 Aventis Pharma S.A. Use of a taxoid to treat abnormal cell proliferation in the brain
US6403634B1 (en) 1999-01-13 2002-06-11 Aventis Pharma S.A. Use of taxoid derivatives
IT1308636B1 (it) 1999-03-02 2002-01-09 Indena Spa Procedimento per la preparazione di tassani da 10-desacetilbaccatinaiii.
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
WO2002066448A1 (en) * 2001-02-20 2002-08-29 Dabur India Limited Method of preparation of paclitaxel (taxol) using 3-(alk-2-ynyloxy) carbonyl-5-oxazolidine carboxylic acid
JP4108483B2 (ja) * 2001-03-23 2008-06-25 サイノファーム タイワン リミテッド タキサン誘導体の製造方法
US6891050B2 (en) * 2001-08-10 2005-05-10 Dabur India Limited Process for the preparation of taxanes such as paclitaxel, docetaxel and structurally similar analogs
US6881852B2 (en) * 2002-02-05 2005-04-19 Dabur India Limited Process of purification of paclitaxel and docetaxel
US7247738B2 (en) * 2002-05-07 2007-07-24 Dabur India Limited Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl) ethoxycarbonyl]-5-oxazolidine carboxylic acids
US6900342B2 (en) * 2002-05-10 2005-05-31 Dabur India Limited Anticancer taxanes such as paclitaxel, docetaxel and their structural analogs, and a method for the preparation thereof
US6838569B2 (en) 2002-12-16 2005-01-04 Dabur India Limited Process for preparation of paclitaxel trihydrate and docetaxel trihydrate
FR2882362B1 (fr) * 2005-02-23 2007-05-11 Seripharm Procede de preparation du paclitaxel
NZ576355A (en) * 2006-10-20 2012-04-27 Scinopharm Singapore Pte Ltd Process for making crystalline anhydrous docetaxel
PL210984B1 (pl) * 2006-10-31 2012-03-30 Inst Farmaceutyczny Sposób wytwarzania docetakselu
KR100847331B1 (ko) * 2006-12-14 2008-07-21 한미약품 주식회사 도세탁셀의 제조방법 및 이에 사용되는 중간체
KR100921036B1 (ko) 2006-12-18 2009-10-08 한미약품 주식회사 탁산유도체의 제조방법 및 이에 사용되는 중간체
JP5588983B2 (ja) 2008-08-11 2014-09-10 ウェルズ ファーゴ バンク ナショナル アソシエイション マルチアームポリマーアルカノエートコンジュゲート
PL388144A1 (pl) 2009-05-29 2010-12-06 Przedsiębiorstwo Produkcyjno-Wdrożeniowe Ifotam Spółka Z Ograniczoną Odpowiedzialnością Solwaty (2R,3S)-3-tert-butoksykarbonylamino-2-hydroksy-3-fenylopropionianu 4-acetoksy-2α-benzoiloksy -5β,20-epoksy-1,7β,10β-trihydroksy-9-okso-taks-11-en-13α-ylu, sposób ich otrzymywania i zastosowanie
WO2011134067A1 (en) * 2010-04-29 2011-11-03 6570763 Canada Inc. Novel amino acid molecule and uses thereof
US20130338216A1 (en) 2010-12-22 2013-12-19 Nektar Therapeutics Deuterated and/or fluorinated taxane derivatives
US10894087B2 (en) 2010-12-22 2021-01-19 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
US20130331443A1 (en) 2010-12-22 2013-12-12 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
WO2013069027A1 (en) 2011-09-26 2013-05-16 Fresenius Kabi Oncology Ltd. Processes for the preparation of cabazitaxel involving c(7) -oh and c(13) -oh silylation or just c(7) -oh silylation
KR101379694B1 (ko) * 2011-09-30 2014-03-31 주식회사 삼양바이오팜 탁산유도체의 제조방법
CN102382080B (zh) * 2011-12-15 2014-06-18 扬子江药业集团江苏海慈生物药业有限公司 一种多西他赛的制备方法
FR2986526A1 (fr) * 2012-02-03 2013-08-09 Sanofi Sa Procede de preparation de derives du taxol et certains composes intermediaires
CN104650012A (zh) * 2013-11-22 2015-05-27 天士力控股集团有限公司 一种紫杉烷类化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
FR2687151B1 (fr) * 1992-02-07 1994-03-25 Rhone Poulenc Rorer Sa Nouveaux derives de la baccatine iii et de la desacetyl-10 baccatine iii, leur preparation et les compositions pharmaceutiques qui les contiennent.
US5440056A (en) * 1992-04-17 1995-08-08 Abbott Laboratories 9-deoxotaxane compounds

Also Published As

Publication number Publication date
PL308306A1 (en) 1995-07-24
HU9500967D0 (en) 1995-06-28
CZ283362B6 (cs) 1998-03-18
EP0663907A1 (de) 1995-07-26
ZA937319B (en) 1994-04-22
CN1048983C (zh) 2000-02-02
ES2096329T3 (es) 1997-03-01
US5637723A (en) 1997-06-10
HUT72612A (en) 1996-05-28
KR950703547A (ko) 1995-09-20
LT3439B (en) 1995-10-25
FR2696459A1 (fr) 1994-04-08
DE69307527T2 (de) 1997-05-22
SK280624B6 (sk) 2000-05-16
SK43595A3 (en) 1995-08-09
EP0663907B1 (de) 1997-01-15
CA2146155A1 (fr) 1994-04-14
NO310412B1 (no) 2001-07-02
FI951591A (fi) 1995-04-04
FI109791B (fi) 2002-10-15
RU95110686A (ru) 1996-12-27
KR100297197B1 (ko) 2001-11-26
AU5115193A (en) 1994-04-26
AU689081B2 (en) 1998-03-26
MX9305767A (es) 1994-05-31
UA43835C2 (uk) 2002-01-15
CZ84295A3 (en) 1995-09-13
NO951202L (no) 1995-03-29
ATE147735T1 (de) 1997-02-15
LTIP1396A (en) 1995-01-31
DK0663907T3 (da) 1997-02-03
PL179147B1 (pl) 2000-07-31
EE03125B1 (et) 1998-10-15
GEP19981299B (en) 1998-05-01
FR2696459B1 (fr) 1994-11-25
FI951591A0 (fi) 1995-04-04
HU223775B1 (hu) 2005-01-28
CN1087905A (zh) 1994-06-15
JP3014761B2 (ja) 2000-02-28
NO951202D0 (no) 1995-03-29
NZ256446A (en) 1996-06-25
LV10858A (lv) 1995-10-20
SG63619A1 (en) 1999-03-30
CA2146155C (fr) 2003-03-11
RU2116302C1 (ru) 1998-07-27
JPH08501789A (ja) 1996-02-27
LV10858B (en) 1996-06-20
GR3022285T3 (en) 1997-04-30
WO1994007878A1 (fr) 1994-04-14
TW262471B (de) 1995-11-11

Similar Documents

Publication Publication Date Title
ATE147735T1 (de) Verfahren zur herstellung von taxan-derivaten
ES2095081T3 (es) Procedimiento para la preparacion de derivados de taxano.
ATE148882T1 (de) Verfahren zur herstellung von taxan-derivaten
AU5114893A (en) Novel method of esterification of baccatine iii an 10-deacetylbaccatine iii
ATE167179T1 (de) Verfahren zur herstellung von beta-phenylisoserin-derivaten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: AVENTIS PHARMA S.A., ANTONY, FR

8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC